VIR-1111: A Prototype Human CMV-based Vaccine for Human Immunodeficiency Virus (HIV) in Healthy Volunteers

Clinical trial NCT04725877 · COMPLETED

Trial details

NCT number: NCT04725877
Sponsor: Vir Biotechnology, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

HIV I Infection

Start date: 2020-12-28
Primary completion: 2022-12-05
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.